OPTH Fail-to-Deliver

Optimi Health Corp. (OPTH) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry, with a market capitalization near $15.8M, listed on NASDAQ, employing roughly 6 people, carrying a beta of 1.59 to the broader market. Based in Princeton, Canada, Optimi Health Corp. Led by Dane Stevens, public since 2026-05-20.

Fail-to-deliver (FTD) data from the SEC tracks settlement failures where shares were not delivered within the standard settlement period. Persistent FTDs may indicate naked short selling or settlement issues and are monitored by regulators.

Latest Date
2026-07-29
Latest FTD Quantity
682
Latest Price
$4.78
30-Day Avg FTD
6.7K
30-Day Total FTD
166.8K

Showing 25 days of SEC fail-to-deliver data for Optimi Health Corp..

Learn how fails-to-deliver is reported and how to read the data →

Frequently asked OPTH fail to deliver questions

What is the latest OPTH fail-to-deliver count?
As of Jul 29, 2026, Optimi Health Corp. (OPTH) fail-to-deliver quantity is 682 shares, with a 25-day average of 6.7K shares. The SEC publishes FTD data twice monthly: first-half data at month-end, second-half around the 15th of the following month.
What is the FTD aggregate net balance?
FTD figures represent the aggregate net balance in NSCC's Continuous Net Settlement (CNS) system, not the gross failed-share count. The published numbers run 2-6 weeks stale relative to the underlying settlement date.
How do OPTH FTDs affect options pricing?
Persistent FTDs flag hard-to-borrow conditions that distort put-call parity: in HTB names, synthetic long stock (long call + short put at the same strike) trades below the frictionless-parity price by approximately the borrow rebate. The discount equals the lending revenue forgone by holding the synthetic instead of actual shares. Reg SHO threshold-list inclusion follows from sustained FTD persistence.